Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...